Filing Details

Accession Number:
0001209191-23-010616
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2023-02-17 16:25:07
Reporting Period:
2022-12-15
Accepted Time:
2023-02-17 16:25:07
Original Submission Date:
2022-12-16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1796280 Oric Pharmaceuticals Inc. ORIC () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1586894 S Pratik Multani C/O Oric Pharmaceuticals, Inc.
240 E. Grand Ave., 2Nd Floor
South San Francisco CA 94080
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-12-15 2,227 $3.07 7,285 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This amendment is filed to correct the number of shares sold, and the price per share at which the shares were sold, to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person.